Celldex Therapeutics, Inc (CLDX)
Health Care – IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Headquarters
- United States
- Employees
- 198
- Market Cap
- $3.3B
About Celldex Therapeutics, Inc
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
SentiSense also tracks daily options readings for Celldex Therapeutics, Inc: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Celldex Therapeutics, Inc stock analysis, sentiment tracking, and market intelligence on SentiSense.